Sequenom, Inc.

• Three Monday Upgrades That You May Want to Ignore

  By Brian Nichols - May 15, 2013 | Tickers: SQNM, BA, WCRX

  An analyst’s upgrade almost always causes a stock to trend higher. However, those gains can often be a value-trap. In this piece, I am looking at three such stocks; those that I believe are presenting a value trap to investors.

  Avoid the Large Buyout Rumors

  Warner-Chilcott (NASDAQ: WCRX) saw a slew of upgrades from firms Morgan Stanley, UBS, and CRT Capital, all of whom are buying the idea of more »

• 3 Bio-Techs Insiders Love

  By Mohsin Saeed - March 19, 2013 | Tickers: INFI, MNKD, SQNM

  The biotechnology industry has given exceptional returns in the last couple of years. Quite a few stocks have soared due to FDA approval of their respective drugs. The high number of expiring patents has also forced larger bio-pharmaceutical companies to adopt aggressive acquisition strategies.

  The following three companies have seen strong insider buying during the last six months. This can be an indication of positive catalysts approaching because insiders have more »

• Upcoming Reports Are Make-or-Break for These Companies

  By John Macris - March 7, 2013 | Tickers: FL, P, SQNM

  As of this writing on March 6, the Dow Jones Industrial Average continues to make record highs.
  
  I am not a believer in timing the market as a long-term investor. However, over the last three weeks I have been selling my stocks and have hardly put any new money to work. I am universally in agreement with the market pessimists who believe that market strength is being driven by global more »

• Four Analyst Upgrades that I Would Not Chase

  By Brian Nichols - March 4, 2013 | Tickers: ISRG, NSPH, SQNM, WNR

  An analyst’s call can be a major swing in momentum for a stock, creating a domino effect of revised outlooks and either buying or selling. Here are four stocks that traded with excessive volatility last Friday thanks to the notes issued by analysts; these are all calls worth noting that might not result in long-term gains.

  Company	Ticker	Firm	Call
  Western Refining	(NYSE: WNR)	Barclays	Overweight
  Nanosphere	(NASDAQ: NSPHmore »)

• Kevin DeGeeter's Best Idea Yet

  By Streetwise Reports - May 11, 2012 | Tickers: SQNM

  George S. Mack, The Life Sciences Report

  For more interviews with sector experts and analysts, please sign up for our newsletter at www.thelifesciencesreport.com

  Genetic tests move from research lab to physician's office.

  Personalized medicine and targeted therapeutics are about narrowing down disease to achieve more definitive diagnostics and then finding more precise therapies. One could argue that every person's cancer is a different disease because the more »

• Great Values Among Battered Medical Technology Stocks

  By Streetwise Reports - April 19, 2012 | Tickers: BIO, GE, MYGN, SQNM, VAR

  Subscribe to The Life Sciences Report for more interviews with life sciences and biotech analysts.

  --------------

  George S. Mack, The Life Sciences Report

  A new device must offer a tangible bottom-line advantage.

  No industry in the healthcare sector has been shrouded with more pessimism than medical technology. It would be easy to check off all the boxes on your list of gloomy headwinds, dust off your hands and find another story more »